Indication
Left Ventricular Hypertrophy
5 clinical trials
11 products
2 drugs
Product
AmlodipineProduct
LosartanClinical trial
A Prospective, Multicentre, Randomized, Open Label, Evaluator-Blind, Phase IV Study to Evaluate the Effect on Improvement of Left Ventricular Hypertrophy by the Control of Blood Pressure in Hypertension Patients With Aortic Valve DiseaseStatus: Completed, Estimated PCD: 2022-07-25
Product
Current TreatmentProduct
Losartan + AmlodipineClinical trial
A Study to Evaluate Accuracy and Validity of the Chang Gung ECG Abnormality Detection SoftwareStatus: , Estimated PCD: 2024-01-31
Clinical trial
Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in HypertensionStatus: Recruiting, Estimated PCD: 2026-09-01
Product
EplerenoneProduct
ChlorthalidoneProduct
PotassiumClinical trial
Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor (ARNI) With Amlodipine on Ventricular Remodeling in Hypertension and Left Ventricular Hypertrophy.Status: Recruiting, Estimated PCD: 2023-06-01
Product
sacubitril/valsartanDrug
AmlodipineClinical trial
Empagliflozin and Cardiac Remodelling in People Without DiabetesStatus: Completed, Estimated PCD: 2022-07-31
Product
EmpagliflozinDrug
Varlilumab